Today’s news
Boston Scientific Touts 'Practice-Transforming' Trial Data for PE and AF
Executives highlight new clinical trial results at ACC conference call, describing potential impact on treatment guidelines.
PCSK9 Inhibitor Shown Highly Effective in High-Risk Patients Without Prior Heart Disease
New data from the VESALIUS-CV trial challenges conventional wisdom on aggressive cholesterol-lowering therapy.
Poor Cardiac Structure Tied to Higher Long-term Risks
Study finds increased heart chamber size and weight linked to higher chances of mortality, cardiovascular disease, dementia, and other conditions later in life.
